Mechanism-based inactivation of cytochrome P450 3A4 by methylenedioxyphenyl lignans from Aconthoponox chiisonensis

被引:13
作者
Yoo, Hye Hyun [1 ]
Lee, Sang-Hyun [2 ]
Jin, Changbae [1 ]
Kim, Dong-Hyun [1 ]
机构
[1] Korea Inst Sci & Technol, Doping Control Ctr, Seoul 136791, South Korea
[2] Chung Ang Univ, Coll Ind Sci, Dept Appl Plant Sci, Gyeonggi Do, South Korea
关键词
Acanthopanax chiisanensis; Araliaceae; methylenedioxyphenyl lignans; CYP3A4; mechanism-based inactivation;
D O I
10.1055/s-2008-1074556
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The purpose of this investigation is to characterize the inhibition of CYP3A4 by methylenedioxyphenyl lignans isolated from Acanthopanax chiisanensis. Inhibition of CYP3A4 by three methylenedioxyphenyl lignans, avinin, helioxanthin, and 3-(3 '',4 ''-dimethoxybenzyl)-2-(3',4'-methylenedioxybenzyl)butyrolactone was time-, concentration-, and NADPH-dependent and characterized by K-1 values of 2.4, 1.6, and 2.2 mu M and k(inact) values of 0.030, 0.043, and 0.047 min(-1) respectively. The inhibition of CYP3A4 activity by these lignans was suppressed in the presence of a competitive CYP3A4 substrate, ketoconazole. Addition of nucleophiles or reactive oxygen scavenger and dialysis did not prevent inactivation of CYP3A4 by the Acanthopanax lignans. The loss of CYP3A4 enzymatic activity resulting from incubation with the Acanthopanax lignans was accompanied with a spectral loss of CYP3A4. These results collectively demonstrate that savinin, helioxanthin and 3-(3 '',4 ''-dimethoxybenzyl)-2(3',4'-methylenedioxybenzyl)butyrolactone from A. chiisanensis inactivate CYP3A4 in a mechanism-based mode.
引用
收藏
页码:822 / 827
页数:6
相关论文
共 21 条
  • [1] Inhibition of prostaglandin E2 production by taiwanin C isolated from the root of Acanthopanax chiisanensis and the mechanism of action
    Ban, HS
    Lee, S
    Kim, YP
    Yamaki, K
    Shin, KH
    Ohuchi, K
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (09) : 1345 - 1354
  • [2] Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components
    Chatterjee, P
    Franklin, MR
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (11) : 1391 - 1397
  • [3] Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomes
    Chiba, M
    Nishime, JA
    Chen, IW
    Vastag, KJ
    Sahly, YS
    Kim, BM
    Dorsey, BD
    Vacca, JP
    Lin, JH
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 56 (02) : 223 - 230
  • [4] FRANKLIN M R, 1971, Xenobiotica, V1, P581
  • [5] Maximal inhibition of intestinal first-pass metabolism as a pragmatic indicator of intestinal contribution to the drug-drug interactions for CYP3A4 cleared drugs
    Galetin, Aleksandra
    Hinton, Laura K.
    Burt, Howard
    Obach, R. Scott.
    Houston, J. Brian
    [J]. CURRENT DRUG METABOLISM, 2007, 8 (07) : 685 - 693
  • [6] Potent inhibition of human cytochrome P450, 2D6, 2C9 isoenzymes by grapefruit juice and its furocoumarins
    Girennavar, B.
    Jayaprakasha, G. K.
    Patil, B. S.
    [J]. JOURNAL OF FOOD SCIENCE, 2007, 72 (08) : C417 - C421
  • [7] Inhibition of cytochrome P450 3A4 by a pyrimidineimidazole: Evidence for complex heme interactions
    Hutzler, J. Matthew
    Melton, Roger J.
    Rumsey, Jeanne M.
    Schnute, Mark E.
    Locuson, Charles W.
    Wienkers, Larry C.
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1650 - 1659
  • [8] Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract
    Iwata, H
    Tezuka, Y
    Kadota, S
    Hiratsuka, A
    Watabe, T
    [J]. DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) : 1351 - 1358
  • [9] Iwata Hiroshi, 2005, Drug Metab Pharmacokinet, V20, P34, DOI 10.2133/dmpk.20.34
  • [10] JULSING MK, EUR J MED C IN PRESS